Obstructive Sleep Apnea Diagnosis and Treatment - part 9 doc

362 Bhatt and Chokroverty 13. Malow BA, Levy K, Maturen K, et al. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 2000; 55(7):1002–1007. 14. Vaughn BV, D’Cruz OF. Obstructive sleep apnea in epilepsy. Clin Chest Med 2003; 24(2):239–248. 15. Chokroverty S, Sachdeo R, Goldhammer T, et al. Epilepsy and sleep apnea. Electroencephalogr Clin Neurophysiol 1985; 61:26 [Abstract]. 16. Chokroverty S, Siddiqui F, Rafiq S, Walters A. Comorbid epilepsy and sleep apnea. J N J Neurosci Inst 2006; 1:12–15. 17. Tirosh E, Tal Y, Jaffe M. CPAP treatment of obstructive sleep apnoea and neurodevel- opment deficits. Acta Paediatr 1995; 84:791–794. 18. Koh S, Ward SL, Lin M, et al. Sleep apnea treatment improves seizure control in children with neurodevelopmental disorders. Pediatr Neurol 2000; 22:36–39. 19. Manni R, Terzaghi M, Arbasino C, et al. Obstructive sleep apnea in a clinical series of adult epilepsy patients: frequency and features of the comorbidity. Epilepsia 2003; 44(6):836–840. 20. de Almeida CA, Lins OG, Lins SG, et al. Sleep disorders in temporal lobe epilepsy. Arq Neuropsiquiatr 2003; 61(4):979–987 [Article in Portuguese]. 21. Sonka K, Juklickova M, Pretl M, et al. Seizures in sleep apnea patients: occurrence and time distribution. Sb Lek 2000; 101:229–232. 22. Vaughn BV, D’Cruz OF, Beach R, et al. Improvement of epileptic seizure control with treatment of obstructive sleep apnoea. Seizure 1996; 5:73–78. 23. Malow BA, Weatherwax KJ, Chervin RD, et al. Identification and treatment of obstruc- tive sleep apnea in adults and children with epilepsy: a prospective pilot study. Sleep Med 2003; 4(6):509–515. 24. Dinesen H, Gram L, Anderson T, et al. Weight gain during treatment with valproate. Acta Neurol Scand 1984; 70:65–69. 25. Robinson R, Zwillich C. Drugs and sleep respiration. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine. Philadelphia, PA: Saunders, 1994: 603–620. 26. Nagarajan L, Walsh P, Gregory P, et al. Respiratory pattern changes in sleep in children on vagal nerve stimulation for refractory epilepsy. Can J Neurol Sci 2003; 30(3): 224–227. 27. Holmes MD, Chang M, Kapur V. Sleep apnea and excessive daytime somnolence induced by vagal nerve stimulation. Neurology 2003; 61(8):1126–1129. 28. Marzec M, Edwards J, Sagher O, et al. Effects of vagus nerve stimulation on sleep- related breathing in epilepsy patients. Epilepsia 2003; 44(7):930–935. 29. Jarrell L. Preoperative diagnosis and postoperative management of adult patients with obstructive sleep apnea syndrome: a review of the literature. J Perianesth Nurs 1999; 14:193–200. 30. American Academy of Sleep Medicine: International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005. 31. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in adults. Sleep 2005; 28:1049–1057. 32. Ohayon MM. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev 2002; 6:97–111. 33. Krakow B. An emerging interdisciplinary sleep medicine perspective on the high prev- alence of co-morbid sleep-disordered breathing and insomnia. Sleep Med 2004; 5(5):431–433. 34. Krakow B, Melendrez D, Ferreira E, et al. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 2001; 120(6):1923–1929. 35. Smith S, Sullivan K, Hopkins W, et al. Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Sleep Med 2004; 5(5):449–456. 36. Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005; 28(3):309–314. Other Sleep Disorders 363 37. Guilleminault C, Palombini L, Poyares D, et al. Chronic insomnia, premenopausal women and sleep disordered breathing. Part 2: Comparison of nondrug treatment trials in normal breathing and UARS post menopausal women complaining of chronic insomnia. J Psychosom Res 2002; 53(1):525–527. 38. Lichstein K, Riedel B, Letere K, et al. Occult sleep apnea in a recruited sample of older adults with insomnia. J Consult Clin Psychol 1999; 67:405–410. 39. Littner M, Hirshkowitz M, Kramer M, et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for using polysomno- graphy to evaluate insomnia: an update for 2002. Sleep 2003; 26(6):754–760. 40. Chung KF, Krakow B, Melendez D, et al. Relationships between insomnia and sleep- disordered breathing. Chest 2003; 123(1):310–313. 41. Chung KF. Insomnia subtypes and their relationships to daytime sleepiness in patients with obstructive sleep apnea. Respiration 2005; 72(5):460–465. 42. Krakow B, Germain A, Tandberg D, et al. Sleep breathing and sleep movement disor- ders masquerading as insomnia in sexual-assault survivors. Compr Psychiatry 2000; 41(1):49–56. 43. Krakow B, Melendrez D, Warner TD, et al. To breathe, perchance to sleep: sleep-disor- dered breathing and chronic insomnia among trauma survivors. Sleep Breath 2002; 6(4):189–202. 44. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/ hypopnoea syndrome (SAHS). Sleep Med Rev 2003; 7:81–99. 45. Krakow B, Melendrez D, Lee SA, et al. Refractory insomnia and sleep-disordered breathing: a pilot study. Sleep Breath 2004; 8(1):15–29. 46. Collop NA. Can’t Sleep? You May Have Sleep Apnea! Chest 2001; 120:1768–1769. 47. Crabtree VM, Varni JW, Gozal D. Health-related quality of life and depressive symp- toms in children with suspected sleep-disordered breathing. Sleep 2004; 27(6): 1131–1138. 48. Brown WD. The psychosocial aspects of obstructive sleep apnea. Semin Respir Crit Care Med 2005; 26(1):33–43. 49. Sharafkhaneh A, Giray N, Richardson P, et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28(11):1405–1411. 50. Reynolds CF III, Coble PA, Spiker DG, et al. Prevalence of sleep apnea and nocturnal myoclonus in major affective disorders: clinical and polysomnographic findings. J Nerv Ment Dis 1982; 170(9):565–567. 51. Farney RJ, Lugo A, Jensen RL, et al. Simultaneous use of antidepressant and antihyper- tensive medications increases likelihood of diagnosis of obstructive sleep apnea syn- drome. Chest 2004; 125(4):1279–1285. 52. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry 2003; 64(10):1195–1200. 53. Sforza E, de Saint Hilaire Z, Pelissolo A, et al. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med 2002; 3(2):139–145. 54. Yue W, Hao W, Liu P, et al. A case-control study on psychological symptoms in sleep apnea–hypopnea syndrome. Can J Psychiatry 2003; 48(5):318–323. 55. Aloia MS, Arnedt JT, Smith L, et al. Examining the construct of depression in obstruc- tive sleep apnea syndrome. Sleep Med 2005; 6(2):115–121. 56. Deldin P, Phillips LK, Thomas RJ. A preliminary study of sleep-disordered breathing in major depressive disorder. Sleep Med 2006; 7(2):131–139. 57. Pillar G, Lavie P. Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest 1998; 114(3):697–703. 58. Millman RP, Fogel BS, McNamara ME, et al. Depression as a manifestation of obstruc- tive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry 1989; 50(9):348–351. 59. Sanchez AI, Buela-Casal G, Bermudez MP, et al. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin Neurosci 2001; 55(6):641–646. 364 Bhatt and Chokroverty 60. McMahon JP, Foresman BH, Chisholm RC. The influence of CPAP on the neurobehav- ioral performance of patients with obstructive sleep apnea hypopnea syndrome: a sys- tematic review. Wisconsin Med J 2003; 102:36–43. 61. Means MK, Lichstein KL, Edinger JD, et al. Changes in depressive symptoms after con- tinuous positive airway pressure treatment for obstructive sleep apnea. Sleep Breath 2003; 7(1):31–42. 62. Schwartz DJ, Kohler WC, Karatinos G. Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest 2005; 128(3):1304–1309. 63. Kawahara S, Akashiba T, Akahoshi T, et al. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syn- drome. Intern Med 2005; 44(5):422–427. 64. Hilleret H, Jeunet E, Osiek C, et al. Mania resulting from continuous positive airways pressure in a depressed man with sleep apnea syndrome. Neuropsychobiology 2001; 43(3):221–224. 65. Kjelsberg FN, Ruud EA, Stavem K. Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med 2005; 6(4):341–346. 66. Li HY, Huang YS, Chen NH, et al. Mood improvement after surgery for obstructive sleep apnea. Laryngoscope 2004; 114(6):1098–1102. 67. Yu BH, Ancoli-Israel S, Dimsdale JE. Effect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res 1999; 33(5):427–432. 68. O’Hara R, Schröder C. Unraveling the relationship of obstructive sleep-disordered breathing to major depressive disorder. Sleep Med 2006; 7(2):101–103. 69. Aloia MS, Arnedt JT, Davis JD, et al. Neuropsychological sequelae of obstructive sleep apnea–hypopnea syndrome: a critical review. J Int Neuropsychol Soc 2004; 10(5): 772–785. 70. Schuld A, Hebebrand J, Geller F, et al. Increased body mass index in patients with narcolepsy. Lancet 2000; 355(9211):1274–1275. 71. Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy–cataplexy across ethnic groups. Sleep 2002; 25(1):27–35. 72. Harsh J, Peszka J, Hartwig G, et al. Night-time sleep and daytime sleepiness in nar- colepsy. J Sleep Res 2000; 9(3):309–316. 73. Chokroverty S. Sleep apnea in narcolepsy. Sleep 1986; 9(1 Pt 2):250–253. 74. Guilleminault C, Eldrige F, Dement WC. Insomnia, narcolepsy and sleep apnea. Bell Eur Physiopathol Respir 1972; 8:1127–1138. 75. Guilleminault C, Van Den Hoed J, Mitler MM. Clinical overview of the sleep apnea syndrome. In: Guilleminault C, Dement WC, eds. Sleep apnea syndrome. New York: Alan R. Liss, Inc., 1978:1–12. 76. Laffont F, Autret A, Minz M, et al. Sleep respiratory arrythmia in control subjects, nar- coleptics and non-cataplectic hypersomniacs. Electroencephalogr Clin Neurophysiol 1978; 44:697–705. 77. Carpio MV, Carmona BC, Garcia DE, Botebol BG, Cano GS, Capote GF. Association of obstructive apnea syndrome during sleep and narcolepsy. Arch Bronconeumol 1998; 34(6):310–311 [Article in Spanish]. 78. Littner MR, Kushida C, Wise M, et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28(1):113–121. 79. Aldrich MS, Chervin RD, Malow BA. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997; 20(8):620–629. 80. Bishop C, Rosenthal L, Helmus T, et al. The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness. Sleep 1996; 19(9):727–730. 81. Chervin RD, Aldrich MS. Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med 2000; 161(2 Pt 1):426–431. 82. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59(10):1553–1562. Other Sleep Disorders 365 83. Kanbayashi T, Inoue Y, Kawanishi K, et al. CSF hypocretin measures in patients with obstructive sleep apnea. J Sleep Res 2003; 12(4):339–341. 84. Allen RP, Hening WA, Montplaisir J, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from The RLS Diagnosis and Epidemiology Workshop at the National Institute of Health. Sleep Med 2003; 4(2):101–119. 85. Montplaisir J, Boucher S, Poirier G, et al. Clinical polysomnographic and genetic char- acteristics of restless legs syndrome: a study of 133 patients diagnosed with new stand- ard criteria. Mov Disord 1996; 12:61–65. 86. American Sleep Disorders Association Task Force. Recording and scoring leg move- ments. Sleep 1993; 16:748–759. 87. Stoohs RA, Blum HC, Suh BY, et al. Misinterpretation of sleep-breathing disorder by periodic limb movement disorder. Sleep Breath 2001; 5(3):131–137. 88. Sforza E, Nicolas A, Lavigne G, et al. EEG and cardiac activation during periodic leg movements in sleep: Support for a hierarchy of arousal responses. Neurology 1999; 52:786–791. 89. Siddiqui F, Walters A, Ming X, Chokroverty S. Rise of blood pressure with periodic limb movements in sleep in patients with restless legs syndrome. Neurology 2005; 20:S65 [Abstract]. 90. Karadenitz D, Ondze B, Besset A, et al. EEG arousals and awakenings in relation with periodic leg movements during sleep. J Sleep Res 2000; 9:273–277. 91. Martin SE, Wraith PK, Deary IJ, et al. The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med 1997; 155:1596–1601. 92. Michaud M, Paquet J, Lavigne G, et al. Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol 2002; 48:108–113. 93. Lakshminarayanan S, Paramasivan KD, Walters AS, et al. Clinically significant but unsuspected restless legs syndrome in patients with sleep apnea. Mov Disord 2005; 20(4):501–503. 94. Rodrigues RND, Rodrigues AAS, Pratesi R, et al. Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the associa- tion of RLS and obstructive sleep apneas. Sleep Med 2006; 7:235–239. 95. Haba-Rubio J, Staner L, Krieger J, et al. Periodic limb movements and sleepiness in obstructive sleep apnea patients. Sleep Med 2005; 6(3):225–229. 96. Montplaisir J, Michaud M, Denesle R, et al. Periodic leg movements are not more prev- alent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment. Sleep 2000; 1:163–167. 97. Schenck CH, Hurwitz TD, Mahowald MW. Symposium: normal and abnormal REM sleep regulation: REM sleep behavior disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res 1993; 2:224–231. 98. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: Development of a scoring method. Neurology 1992; 42(7):1371–1374. 99. Warnes H, Dinner DS, Kotagal P. Periodic limb movements and sleep apnoea. J Sleep Res 1993; 2(1):38–44. 100. Briellmann RS, Mathis J, Bassetti C, et al. Patterns of muscle activity in legs in sleep apnea patients before and during nCPAP therapy. Eur Neurol 1997; 38(2):113–118. 101. Fry JM, DiPillipo MA, Pressman MR. Periodic leg movements in sleep following treat- ment of obstructive sleep apnea with nasal continuous positive airway pressure. Chest 1989; 96:89–91. 102. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbance? Sleep 1996; 19:219–223. 103. Mahowald MW. Assessment of periodic leg movements is not an essential component of overnight sleep study. Am J Respir Crit Care Med 2001; 167:1340–1341. 104. Chervin RD. Periodic leg movements and sleepiness in patients evaluated for sleep- disordered breathing. Am J Respir Crit Care Med 2001; 164(8 Pt 1):1454–1458. 105. Johns M. Rethinking the assessment of sleepiness. Sleep Med Rev 1998; 2:3–15. 106. Cluydts R, De Valck E, Verstraeten E, et al. Daytime sleepiness and its evaluation. Sleep Med Rev 2002; 6:83–96. 107. Guilleminault C, Palombini L, Pelayo R, et al. Sleepwalking and sleep terrors in prepu- bertal children: what triggers them? Pediatrics 2003; 111(1):e17–25. 366 Bhatt and Chokroverty 108. Guilleminault C, Kirisoglu C, Bao G, et al. Adult chronic sleepwalking and its treatment based on polysomnography. Brain 2005; 128(Pt 5):1062–1069. 109. Guilleminault C, Kirisoglu C, da Rosa AC, et al. Sleepwalking, a disorder of NREM sleep instability. Sleep Med 2006; 7(2):163–170. 110. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demo- graphic, clinical and laboratory findings in 93 cases. Brain 2000; 123:331–339. 111. Schenck CH, Milner DM, Hurwitz TD, et al. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 1989; 146:1166–1173. 112. Iranzo A, Santamaria J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep 2005; 28(2):203–206. 113. Schenck CH, Hurwitz TD, O’Connor KA, et al. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep 1993; 16(5):457–466. 114. Schenck CH, Mahowald MW. Review of nocturnal sleep-related eating disorders. Int J Eat Disord 1994; 15(4):343–356. 115. Eveloff SE, Millman RP. Sleep-related eating disorder as a cause of obstructive sleep apnea. Chest 1993; 104(2):629–630. 116. Schenck C, Hurwitz T, Bundlie S, et al. Sleep-related eating disorders: polysomno- graphic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep 1991; 14:419–431. 117. Espa F, Dauvilliers Y, Ondze B, et al. Arousal reactions in sleepwalking and night terrors in adults: the role of respiratory events. Sleep 2002; 25(8):871–875. 118. Comella C, Tevens S, Stepanski E, et al. Sensitivity analysis of the clinical diagnostic criteria for REM behavior disorder (RBD) in Parkinson’s disease. Neurology 2002; 58(suppl3):A434. 119. Millman RP, Kipp GJ, Carskadon MA. Sleepwalking precipitated by treatment of sleep apnea with nasal CPAP. Chest 1991; 99(3):750–751. 367 Neurological Disorders Maha Alattar and Bradley V. Vaughn Department of Neurology, University of North Carolina, Chapel Hill, North Carolina, U.S.A. INTRODUCTION Sleep and breathing are both controlled by the brain. A wide range of neurological disorders has significant impact on sleep-related breathing. Features of hypoventi- lation, obstructive, and central apneas may all be manifestations of neurological disorders and these disorders may impact on the individual’s neurological function. The dynamic relationship of the nervous system to sleep-related breathing is most striking in individuals who have lesions in their central nervous system (CNS) and sleep apnea. For some of these individuals, disruption of breathing in sleep results in worsening of their overall condition and improvement in breathing results in a global benefit. In others, however, the sleep-related breathing issue appears to parallel their neurological condition and treatment may result in little benefit. Unfortunately for the clinician, the distinction between these two groups is not always clear. Although obstructive sleep apnea (OSA) may be one of the more common sleep-related breathing disorders (SRBDs), clinicians must also be aware that other respiratory issues may impact patients with neurological disorders. Treatment of any SRBD offers an opportunity to improve quality of life. In this chapter, we will explore the relationship of sleep and breathing to a variety of neurological condi- tions and describe some of the therapeutic approaches and pitfalls. NEUROLOGICAL LOCALIZATION OF RESPIRATION The organ of control over breathing, the brain, orchestrates respiration through many layers of neural circuitry. From the respiratory-related muscles, peripheral receptors and nerves to brainstem, midbrain and cortical feedback loops, a variety of inputs augment and regulate ventilation and respiration. This multilayered control system permits for a variety of ventilatory patterns that can give clues to the site of potential neurological dysfunction (1) (Table 1). The ventilatory cycle relies upon sensory inputs to estimate the somatic requirements. This sensory input is derived primarily from three components: (i) the vagus nerve relaying information from the pulmonary stretch receptors in the lung and aorta, (ii) the intercostals nerves and spinal cord relaying positional sense from the chest wall, (iii) and the chemoception. Chemoception utilizes two sensory areas: central and peripheral. Central chemoceptors are predominantly on the ven- tral aspect of the medulla. These receptors sense acid and carbon dioxide. The peripheral chemoceptors are in the aorta and carotid body and their information are relayed via the glossopharyngeal nerve. The carotid chemoceptors detect the oxygen content of the arterial blood. These sensors increase their firing rates when oxygen levels fall. These sensory nerves are typically myelinated but also convey some input via partially myelinated and unmyelinated axons. Processes such as diabetes 22 368 Alattar and Vaughn mellitus, Guillain-Barré syndrome or porphyria can damage these nerves. Although pure sensory loss of these nerves is exceedingly rare, damage of these nerves is typi- cally accompanied with loss of motor function. If pure sensory nerve loss did occur the peripheral feedback of information to the medulla would be diminished, and patients would rely upon central chemoceptors for feedback regulation. At the level of the medulla, we find the first layers of respiratory cycle genera- tors. Neurons in the nucleus solitarius, ambiguous, and retroambigualis work in concert to initially match ventilation to respiratory demand. The ventilatory cycle is composed of three phases: inspiration, postinspiration, and expiration. Respiratory neurons in the medulla and pons discharge in a pattern correlating to one of these phases. Together these neurons form the central pattern generator that orchestrates the cyclic activation of the respiratory musculature. This central pattern generator is composed of predominately three neuronal groups. Nogues categorized these as dorsal respiratory group, ventral respiratory group, and pontine respiratory group (2). The dorsal respiratory group is in the ventrolateral subnucleus of the nucleus tractus solitarius. This neuronal group is TABLE 1 Central and Peripheral Nervous System Lesions and Their Associated Neurological Disorders, Ventilatory Patterns, and Potential Sleep-Related Breathing Disorders Location Non-state-dependent breathing issue Disorders of the area Potential sleep- related breathing disorder Cerebral cortex Cheyne-Stokes post- hyperventilation pause Stroke, tumor, multiple sclerosis, trauma, encephalitis Obstructive sleep apnea, central sleep apnea, Cheyne-Stokes breathing Midbrain Central hyperventilation Progressive supranuclear palsy, Parkinson’s disease, tumor Central sleep apnea Pons Apneustic, biots Multiple sclerosis, tumors, strokes Central sleep apnea Medulla Ataxic breathing Chiari malformations, multiple sclerosis, stroke, tumor Central sleep apnea, obstruc- tive sleep apnea Spinal cord At or above C3–5: no respiratory effort, C5–T8: potential impaired chest wall motion, difficulty with expiration and potential hypoventilation Multiple sclerosis, trauma, myelitis, syringomyelia, tumor Hypoventilation Peripheral nerve Respiratory cycle issues with severe sensory and motor neuropathies Guillain-Barré syndrome, porphyria, diabetes mellitus Central apnea, hypoventilation Neuromuscular junction Hypoventilation with fatigue Myasthenia gravis, Lambert-Eaton syndrome Obstructive sleep apnea, hypoventilation Muscle Hypoventilation with fatigue Myotonic dystrophy, Duchenne muscular dystrophy, polymyositis Hypoventilation Neurological Disorders 369 primarily active during inspiration receiving input from pulmonary vagal afferents. Many of these neurons excite lower motor cranial nerves that dilate the upper airway prior to excitation of the contralateral phrenic and intercostal neurons in the spinal cord. This coordinated output must occur in the correct timed sequence to permit the movement of air through a patent airway. Other neurons in this same group receive input from baroreceptors and cardiac receptors influencing several other respiratory-related reflexes (e.g., coughing, sneezing). The ventral respiratory group is located in the ventral lateral medulla from the top of the cervical cord to the level of the facial nerve. This group contains the BÖtzinger complex, the preBÖtzinger neurons, the rostral portion of nucleus ambiguous, and nucleus retroambigualis. The BÖtzinger complex contains neurons that are active during expiration and inhibit inspiration. The preBÖtzinger complex contains propriobulbar neurons that participate in generating the rhythm of respira- tion. The caudal portion of this group is primarily composed of expiratory neurons that project to intercostal, abdominal, and external sphincter motor neurons. Although these primary drivers form a rudimentary cycle, neurons in the ventral and midline medulla appear to have plasticity in response to intermittent hypox- emia to augment respiratory responses (3). Lesions in the medulla may produce ataxic breathing, agonal respiration or an absence of respiration. The pontine respiratory group adds another layer of control. This group is localized to the dorsal lateral pons and is important in stabilizing the respiratory pattern. These neurons are influenced by both inspiratory and expiratory inputs and help determine the length of inspiration and expiration (1). Typically, the destruction of these neurons lengthens the duration of inspiration. Lesions of the caudal pons may also produce apneustic respiration, and lesions in the mid- brain or posterior hypothalamus may produce hyperventilatory responses. These types of respiratory abnormalities may result from strokes, tumors or demyelin- ating plaques. The voluntary control over respiration primarily resides in the cerebral cortex and diencephalon. The cortex is responsible for initiating the intricate respi- ratory control involved in speech, eating, and singing. As an individual enters sleep, the cortical control over sleep is altered and may allow the emergence of SRBD. With cortical injury, patients may have prolonged posthyperventilatory apnea or Cheyne-Stokes respiration (CSR). The CSR may be more prominent or only present in sleep (4). The output to the lower respiratory neurons requires transmission of the respiratory effort through the spinal cord to the peripheral nerves. The spinal cord respiratory motor output is divided into two components. The phrenic nerves emerge from the upper cervical cord region (C3–5) to maintain diaphragmatic func- tion. The thoracic levels (T1–T12) innervate the intercostal muscles and the lower thoracic and upper lumbar levels (T6–L3) innervate the abdominal muscles. This division of labor adds a level of assurance of respiration despite the potential of spinal cord injury. The peripheral nerves must deliver the sensory and motor signals. These peripheral nerves are generally well-myelinated, relatively protected from trauma by bone and have limited lengths. These characteristics assure these nerves are less vulnerable to damage compared to most nerves supplying the limbs. In general, nerves with longer courses have greater opportunity to incur injury from trauma, toxins or demyelination, and thus are more likely to demonstrate dysfunction. This may not be true for some etiologies such as porphyrias, or inflammatory 370 Alattar and Vaughn polyradiculopathies, which can afflict more proximal nerves. Individuals with peripheral nerve disorders may demonstrate progressive nocturnal hypoventilation and respiratory failure requiring ventilatory assistance during the more severe por- tions of the disorder (5). In contrast, patients with multiple cranial neuropathies may also demonstrate features of upper airway obstruction. The neuromuscular junction may also be associated with respiratory dysfunc- tion. Respiratory muscles such as the diaphragm may require less depolarization to reach firing threshold and thus these muscles may not be the first affected by neuro- muscular dysfunction. The range of SRBDs affected by neuromuscular dysfunction is exemplified in myasthenia gravis (MG), as noted subsequently. At the level of the muscle, respiration depends upon adequate contraction of these muscles no matter the sleep–wake state. These lower respiratory muscles include slow-twitch muscle, which generally require the less amount of energy to contract and thus are generally more stable with fatigue (6). Some inherited muscle conditions such as Pompe’s disease (acid maltase deficiency) may primarily affect respiratory muscles causing hypoventilation. This hypoventilation may be more obvious in sleep. Overall, respiration during sleep offers a unique window to view the neuro- logical control over breathing. The entrance into each sleep state creates a change in the regulation over breathing and may allow the emergence of disordered breath- ing. This window may aid in the localization of neurological disease as well as bring insight into the potential causes of SRBD. We have included a table of typical breath- ing patterns and localization of neurological dysfunction (Table 1). As the reader reviews the variety of neurological disorders, the table may provide additional clarity to the secondary respiratory issues. SPECIFIC DISORDERS AND SLEEP APNEA Central Nervous System Disorders Alzheimer’s Disease Alzheimer’s disease is the classical tauopathy characterized by diffuse neuronal loss primarily in the cortex associated with the formation of neurofibrillary tangles and neuritic plaques. The incidence of SRBD in patients with Alzheimer’s disease is unclear. Some investigators have found an increase in SRBD, but in the more posi- tive of studies, the degree of sleep apnea is relatively small. In a cohort of 139 patients, Hoch found that the average apnea–hypopnea index (AHI) for patients with Alzheimer’s was 4.6 whereas the control group was 0.6 (7). This finding was in contrast to Smallwood’s findings, which showed that apnea index was not greater in elderly men with Alzheimer’s than healthy elderly men without sleep complaints (8). Despite the incidence, the question remains: does the apnea drive the neuropathol- ogy or does the dementia cause the breathing disturbance? Untreated sleep apnea has been linked to potential decline in neurocognitive function (9). Although this too has been under debate, some of this decline may be related to vascular issues (9). One component may be the potential link of genetic predisposition to cognitive decline. Apolipoprotein E (APOE) 4 alleles have been associated as a risk factor for the development of Alzheimer’s disease (10). This gene has also been linked to SRBD but to date the resulting cognitive issues have not been linked to APOE 4. Sleep-related respiratory disorders may have a daytime effect in patients with Alzheimer’s. Gehrman (11) found that institutionalized patients with OSA were more likely to have daytime agitation but not night-time agitation suggesting that the SRBD may have some influence on daytime behavior. Neurological Disorders 371 The diagnosis and treatment of SRBD in patients with Alzheimer’s disease can create some challenges. Early in the course of the dementia, most patients can easily adapt to the testing environment with extra instructions. Technologists and healthcare providers must be attuned to the patient’s limited ability to learn new skills and adapt to new settings. These same individuals must remain calm, take extra time to review the procedures, and incorporate multiple teaching aids to help the patient understand. Visual teaching aids along with verbal and written commu- nication may decrease the likelihood of confusion. For many of these patients, the laboratory personnel will find advantageous in having a family member or familiar caregiver in the testing environment to reinforce the communication. In more severely impaired individuals, patients may present significant challenges for electrode application. Making the environment calm with few stimuli may help. Sleep studies may show the patient has typical OSA or mixed apnea. This popula- tion is also at risk for CSR more commonly in Stage 1 and 2 sleeps but this pattern is uncommon in slow-wave sleep and rapid eye movement (REM) sleep. Patients with Alzheimer’s disease and sleep apnea generally accept the con- tinuous positive airway pressure (CPAP) therapy similar to the general population. Ayalon found that these patients used the device an average of 4.8 hours per night (12). The use of CPAP may improve daytime alertness and decrease irritable behavior. Some specific issues may arise in the treatment of this disorder. Individuals may not easily accept therapies such as CPAP or oral appliances thinking the ther- apy may harm them or that they are related to some other aspect of their health. Many of these individuals have memory difficulties and have periods of nocturnal confusion. In general, these individuals may have a better chance of adherence if a family member or caretaker is given the same information regarding the diagnosis and importance of therapy. The caretaker may also consider using some form of behavior modification to help the patient adjust to wearing the CPAP or oral appliance. These techniques may include notes or other messages in prominent and frequented areas, or serial verbal cues before bedtime reminding the patient to use the device. Many medications may influence the patient’s behavior and cognition: thus caregivers should be alert to medications given in the evening that may further confuse the patient. This is also true when considering surgery. These patients have some inherent risk with anesthesia, and will require close supervision following surgery. Most patients with early disease are able to tolerate surgery; this post- operative period is a frequent time for greater confusion and behavior change. Other Forms of Cognitive Impairment Lewy body dementia is also associated with cognitive decline and particular impair- ment of visual spatial tasks. These disorders are noted to have high prevalence of sleep-related complaints based on survey questionnaires, but no study has shown the prevalence of polysomnographic abnormalities in these patients (13). A case report suggests that individuals with autonomic features may have SRBD (14). Cheyne-Stokes breathing and OSA are common findings, but there is no clear link between this form of dementia and sleep apnea. In many of these individuals, treatment follows the same recommendations as those with Alzheimer’s disease. A subgroup of these individuals will have loss of REM sleep atonia and have periods of dream enactment, consistent with a diagnosis of REM sleep behavior disorder. This can become quite dangerous if the patient has a CPAP machine and uncontrolled nocturnal events. For these patients, ade- quate control of the nocturnal events is paramount. This may take a combination of [...]... Peripheral neuropathy in sleep apnea A tissue marker of the severity of nocturnal desaturation Am J Respir Crit Care Med 199 9; 1 59( 1):213–2 19 65 Schnall RP, Shlitner A, Sheffy J, et al Periodic, profound peripheral vasoconstriction—a new marker of obstructive sleep apnea Sleep 199 9; 22(7) :93 9 94 6 66 Ludemann P, Dziewas R, Soros P, et al Axonal polyneuropathy in obstructive sleep apnoea J Neurol Neurosurg... Wochenschr 199 6; 146 (9 10):2 09 210 71 Shintani S, Shiozawa Z, Shindo K, et al Sleep apnea in well-controlled myasthenia gravis Rinsho Shinkeigaku 198 9; 29( 5):547–553 72 Quera-Salva MA, Guilleminault C, Chevret S, et al Breathing disorders during sleep in myasthenia gravis Ann Neurol 199 2; 31(1):86 92 73 Amino A, Shiozawa Z, Nagasaka T, et al Sleep apnoea in well-controlled myasthenia gravis and the effect... sclerosis Brain 199 2; 115 (Pt 2):4 79 494 46 Funakawa I, Yasuda T, Terao A Intractable hiccups and sleep apnea syndrome in multiple sclerosis: report of two cases Acta Neurol Scand 199 3; 88(6):401–405 47 Ferini-Strambi L, Filippi M, Martinelli V, et al Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings J Neurol Sci 199 4; 125(2): 194 – 197 48 Auer... Care Med 199 5; 151(1):123–128 7 Hoch CC, Reynolds CF III, Kupfer DJ, et al Sleep- disordered breathing in normal and pathologic aging J Clin Psychiatry 198 6; 47(10): 499 –503 8 Smallwood RG, Vitiello MV, Giblin EC, et al Sleep apnea: relationship to age, sex, and Alzheimer’s dementia Sleep 198 3; 6(1):16–22 9 Aloia MS, Arnedt JT, Davis JD, et al Neuropsychological sequelae of obstructive sleep apnea hypopnea... headaches and sleep disorders Arch Intern Med 199 7; 157:1701–1705 39 Kiely JL, Murphy M, McNicholas WT Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study Eur Respir J 199 9; 13(5):1086–1 090 40 Poceta JS Sleep- related headache syndromes Curr Pain Headache Rep 2003; 7(4): 281–287 41 Arnulf I, Konofal E, Merino-Andreu M, et al Parkinson’s disease and sleepiness:... airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease J Neurol Neurosurg Psychiatry 199 8; 65(2):225–232 91 Margolis ML, Howlett P, Goldberg R, et al Obstructive sleep apnea syndrome in acid maltase deficiency Chest 199 4; 105(3) :94 7 94 9 92 Mellies U, Ragette R, Schwake C, et al Sleep- disordered breathing and respiratory failure in acid maltase... Stroke and treatment with nasal CPAP Eur J Neurol 2006; 13(2): 198 –200 27 Malow BA, Fromes GA, Aldrich MS Usefulness of polysomnography in epilepsy patients Neurology 199 7; 48(5):13 89 1 394 28 Vaughn BV, D’Cruz OF Obstructive sleep apnea in epilepsy Clinics in Chest Medicine Lee-Chiong T, Mohsenin V, eds Philadelphia, PA: Elsevier Science, 2003; 24:2 39 248 29 Lambert MV, Bird JM Obstructive sleep apnea. .. sleep in patients with myotonic dystrophy Nihon Kyobu Shikkan Gakkai Zasshi 199 0; 28(7): 96 1 97 0 85 Guilleminault C, Cummiskey J, Motta J, et al Respiratory and hemodynamic study during wakefulness and sleep in myotonic dystrophy Sleep 197 8; 1(1): 19 31 86 Finnimore AJ, Jackson RV, Morton A, et al Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function Thorax 199 4; 49( 1):66–70... 342( 19) :1378–1384 21 Young T, Finn L, Hla KM, et al Snoring as part of a dose–response relationship between sleep- disordered breathing and blood pressure Sleep 199 6; 19( suppl 10):S202–S205 22 Yaggi HK, Concato J, Kernan WN, et al Obstructive sleep apnea as a risk factor for stroke and death N Engl J Med 2005; 353( 19) :2034–2041 23 Dziewas R, Humpert M, Hopmann B, et al Increased prevalence of sleep apnea. .. A1 and A2 receptor stimulation on hypoxia induced convulsions in adult mice Pol J Pharmacol 2001; 53:83 92 33 Devinsky O, Ehrenberg B, Bathlen GM, et al Epilepsy and sleep apnea syndrome Neurology 199 4; 44:2060–2064 34 Vaughn BV, D’Cruz OF, Beach R, et al Improvement of epileptic seizure control with treatment of obstructive sleep apnea Seizure 199 6; 5:73–78 35 Koh S, Ward SL, Lin M, et al Sleep apnea . associa- tion of RLS and obstructive sleep apneas. Sleep Med 2006; 7:235–2 39. 95 . Haba-Rubio J, Staner L, Krieger J, et al. Periodic limb movements and sleepiness in obstructive sleep apnea patients Hartwig G, et al. Night-time sleep and daytime sleepiness in nar- colepsy. J Sleep Res 2000; 9( 3):3 09 316. 73. Chokroverty S. Sleep apnea in narcolepsy. Sleep 198 6; 9( 1 Pt 2):250–253. 74. Guilleminault. epilepsy and sleep apnea. J N J Neurosci Inst 2006; 1:12–15. 17. Tirosh E, Tal Y, Jaffe M. CPAP treatment of obstructive sleep apnoea and neurodevel- opment deficits. Acta Paediatr 199 5; 84: 791 – 794 . 18.